USPTO Says Novartis' Patent Term Case Is Time-Barred
The U.S. Patent and Trademark Office on Monday asked a Washington federal court to block Novartis AG's bid to extend patent term adjustments the drugmaker claims unfairly cut short 23 patents,...To view the full article, register now.
Already a subscriber? Click here to view full article